MEGA Hub

Contrastive Multi-Task Learning with Solvent-Aware Augmentation for Drug Discovery

Authors

Do you know Jing Lan?You can claim authorship or link another user.Do you know Hexiao Ding?You can claim authorship or link another user.Do you know Hongzhao Chen?You can claim authorship or link another user.Do you know Yufeng Jiang?You can claim authorship or link another user.Do you know Nga-Chun Ng?You can claim authorship or link another user.Do you know Gerald W. Y. Cheng?You can claim authorship or link another user.Do you know Zongxi Li?You can claim authorship or link another user.Do you know Jing Cai?You can claim authorship or link another user.Do you know Liang-ting Lin?You can claim authorship or link another user.Do you know Jung Sun Yoo?You can claim authorship or link another user.

Abstract

Accurate prediction of protein-ligand interactions is essential for computer-aided drug discovery. However, existing methods often fail to capture solvent-dependent conformational changes and lack the ability to jointly learn multiple related tasks. To address these limitations, we introduce a pre-training method that incorporates ligand conformational ensembles generated under diverse solvent conditions as augmented input. This design enables the model to learn both structural flexibility and environmental context in a unified manner. The training process integrates molecular reconstruction to capture local geometry, interatomic distance prediction to model spatial relationships, and contrastive learning to build solvent-invariant molecular representations. Together, these components lead to significant improvements, including a 3.7% gain in binding affinity prediction, an 82% success rate on the PoseBusters Astex docking benchmarks, and an area under the curve of 97.1% in virtual screening. The framework supports solvent-aware, multi-task modeling and produces consistent results across benchmarks. A case study further demonstrates sub-angstrom docking accuracy with a root-mean-square deviation of 0.157 angstroms, offering atomic-level insight into binding mechanisms and advancing structure-based drug design.

Community

00

Publication notes

Author note
10 pages, 4 figures